Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02555189
Title Enzalutamide With and Without Ribociclib for Metastatic, Castrate-Resistant, Chemotherapy-Naive Prostate Cancer That Retains RB Expression
Recruitment Completed
Gender male
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Sidney Kimmel Cancer Center at Thomas Jefferson University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field